Brought to you by 
Strakan Group acquires OTL Pharma SA
02 Feb 2004
Executive Summary
To expand its commercial operations in Europe, attract additional in-licensing partners, and increase its therapeutic areas, Strakan Group Ltd. (bone and skin disease therapeutics) has acquired specialty drug in-licenser and developer OTL Pharma SA in a cash and stock transaction.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com